Clinical Trial Update: PROTECT: Prospective Trial on Erythropoietin in Clinical Transplantation [Phase 4]

View source ↗

Summary

Phase 4 prospective trial evaluating erythropoietin in kidney transplantation, specifically for recipients of kidneys from non-heart-beating donors, has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• Erythropoietin (erythropoietin)

Snippet

Sponsor: Leiden University Medical Center | Conditions: Patients Receiving a Kidney From a Non-Heart-Beating Donor | Phase 4 | Status: COMPLETED